Dissolution enhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers

References

• Leuner C, Dressman J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm, 50:47–60.
   PubMed Web of Science ®Google Scholar
• Hong SW, Lee BS, Park SJ, Jeon HR, Moon KY, Kang MH et al. (2011). Solid dispersion formulations of megestrol acetate with copovidone for enhanced dissolution and oral bioavailability. Arch Pharm Res, 34:127–135.
   PubMed Web of Science ®Google Scholar
• Dittgen M, Fricke S, Gerecke H, Osterwald H. (1995). Hot spin mixing: a new technology to manufacture solid dispersions. Pharmazie, 50:225–226.
   Web of Science ®Google Scholar
• Breitenbach J. (2002). Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm, 54:107–117.
   PubMed Web of Science ®Google Scholar
• Sekikawa H, Fukuda N, Takada M, Ohtani K, Arita T, Nakano M. (1983). Dissolution behavior and gastrointestinal absorption of dicumarol from solid dispersion systems of dicumarol-polyvinylpyrrolidone and dicumarol-beta-cyclodextrin. Chem Pharm Bull, 31:1350–1356.
   PubMed Web of Science ®Google Scholar
• Caron V, Tajber L, Corrigan OI, Healy AM. (2011). A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone. Mol Pharm, 8:532–542.
   PubMed Web of Science ®Google Scholar
• Wu K, Li J, Wang W, Winstead DA. (2009). Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent. J Pharm Sci, 98:2422–2431.
   PubMed Web of Science ®Google Scholar
• Gong K, Viboonkiat R, Rehman IU, Buckton G, Darr JA. (2005). Formation and characterization of porous indomethacin-PVP coprecipitates prepared using solvent-free supercritical fluid processing. J Pharm Sci, 94:2583–2590.
   PubMed Web of Science ®Google Scholar
• Repka MA, Battu SK, Upadhye SB, Thumma S, Crowley MM, Zhang F et al. (2007). Pharmaceutical applications of hot-melt extrusion: Part II. Drug Dev Ind Pharm, 33:1043–1057.
   PubMed Web of Science ®Google Scholar
• Qi S, Gryczke A, Belton P, Craig DQ. (2008). Characterisation of solid dispersions of paracetamol and EUDRAGIT E prepared by hot-melt extrusion using thermal, microthermal and spectroscopic analysis. Int J Pharm, 354:158–167.
   PubMed Web of Science ®Google Scholar
• Forster A, Hempenstall J, Rades T. (2001). Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers. J Pharm Pharmacol, 53:303–315.
   PubMed Web of Science ®Google Scholar
• Forster A, Hempenstall J, Tucker I, Rades T. (2001). Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int J Pharm, 226:147–161.
   PubMed Web of Science ®Google Scholar
• Rambali B, Verreck G, Baert L, Massart DL. (2003). Itraconazole formulation studies of the melt-extrusion process with mixture design. Drug Dev Ind Pharm, 29:641–652.
   PubMed Web of Science ®Google Scholar
• Six K, Daems T, de Hoon J, Van Hecken A, Depre M, Bouche MP et al. (2005). Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion. Eur J Pharm Sci, 24:179–186.
   PubMed Web of Science ®Google Scholar
• Wang L, Cui FD, Hayase T, Sunada H. (2005). Preparation and evaluation of solid dispersion for nitrendipine-carbopol and nitrendipine-HPMCP systems using a twin screw extruder. Chem Pharm Bull, 53:1240–1245.
   PubMed Web of Science ®Google Scholar
• Jaimini M, Rana AC, Tanwar YS. (2007). Formulation and evaluation of famotidine floating tablets. Curr Drug Deliv, 4:51–55.
   PubMedGoogle Scholar
• Wenning LA, Murphy MG, James LP, Blumer JL, Marshall JD, Baier J et al. (2005). Pharmacokinetics of famotidine in infants. Clin Pharmacokinet, 44:395–406.
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation ofin vitrodrug product dissolution and in vivobioavailability. Pharm Res, 12:413–420.
   PubMed Web of Science ®Google Scholar
• El-Badry M, Fetih G, Fathy M. (2009). Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000. Saudi Pharm J, 17:217–225.
   PubMedGoogle Scholar
• Deasy PB, Law MFL. (1997). Use of extrusion-spheronizationto develops an improved oral dosage form of indomethacin. Int J Pharm, 148:201–209.
   Web of Science ®Google Scholar
• Mady FM, Abou-Taleb AE, Khaled KA, Yamasaki K, Iohara D, Taguchi K et al. (2010). Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine. Int J Pharm, 397:1–8.
   PubMed Web of Science ®Google Scholar
• Hansen CM. (1969). The universality of the solubility parameter. Ind Eng Chem Res Dev, 8:2–11.
   Web of Science ®Google Scholar
• Hoftyzer PJ, Krevelen DWV. (1976). Properties of polymers. Amsterdam, the Netherlands: Elsevier.
   Google Scholar
• Bagley EB, Nelson TP, Scigliano JM. (1971). Three-dimensional solubility parameters and their relationship to internal pressure measurements in polar and hydrogen bonding solvents. J Paint Technol, 43:35–42.
   Web of Science ®Google Scholar
• U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). (1997). Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms. Rockville, MD: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER).
   Google Scholar
• Greenhalgh DJ, Williams AC, Timmins P, York P. (1999). Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci, 88:1182–1190.
   PubMed Web of Science ®Google Scholar
• Hancock BC, Zografi G. (1997). Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci, 86:1–12.
   PubMed Web of Science ®Google Scholar
• Albers J. (2008). Hot-melt extrusion with poorly soluble drugs. Dusseldorf, Germany: Heinrich-Heine-Universitat.
   Google Scholar
• Forster A, Hempenstall J, Tucker, Rades T. (2001). The potential of small-scale fusion experiments and the Gordon-Taylor equation to predict the suitability of drug/polymer blends for melt extrusion. Drug Dev Ind Pharm, 27:549–560.
   PubMed Web of Science ®Google Scholar
• De Brabander C, Van Den Mooter G, Vervaet C, Remon JP. (2002). Characterization of ibuprofen as a nontraditional plasticizer of ethyl cellulose. J Pharm Sci, 91:1678–1685.
   PubMed Web of Science ®Google Scholar